CIK 0001372299
- Non-accelerated filer
- Smaller reporting company
Ocugen, Inc.
Sign in to watch- Ticker
- OCGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 484-328-4701
- Business address
- 11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
- Former names
- HISTOGENICS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,088,801
- in 2 filings, $1.1M under 10b5-1 plans
Net −$1,088,801. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-09 | Kumar Ramesh Director | Grant or award · Option (Right to Buy) | +112,205 | 112,205 | ||
| 2022-10-06 | Kumar Ramesh Director | Option exercise | +4,500 | $0.51 | $2K | 4,500 |
| 2022-10-06 | Kumar Ramesh Director | Sale | −4,500 | $1.83 | $8K | 0 |
| 2022-10-06 | Kumar Ramesh Director | Option exercise · Option (Right to Buy) | −4,500 | 4,500 | ||
| 2022-07-18 | Kumar Ramesh Director | Option exercise | +7,500 | $0.51 | $4K | 7,500 |
| 2022-07-18 | Kumar Ramesh Director | Sale | −7,500 | $2.57 | $19K | 0 |
| 2022-07-18 | Kumar Ramesh Director | Option exercise · Option (Right to Buy) | +7,500 | 9,000 | ||
| 2022-06-07 | Kumar Ramesh Director | Grant or award · Option (Right to Buy) | +140,091 | 140,091 | ||
| 2022-04-18 | Kumar Ramesh Director | Option exercise | +7,500 | $0.51 | $4K | 7,500 |
| 2022-04-18 | Kumar Ramesh Director | Sale | −7,500 | $2.83 | $21K | 0 |
| 2022-04-18 | Kumar Ramesh Director | Option exercise · Option (Right to Buy) | +7,500 | 16,500 | ||
| 2022-01-18 | Kumar Ramesh Director | Option exercise | +7,500 | $0.51 | $4K | 7,500 |
| 2022-01-18 | Kumar Ramesh Director | Sale | −7,500 | $4.07 | $31K | 0 |
| 2022-01-18 | Kumar Ramesh Director | Option exercise · Option (Right to Buy) | +7,500 | 24,000 | ||
| 2021-12-16 | Kumar Ramesh Director | Grant or award · Option (Right to Buy) | +16,335 | 16,335 | ||
| 2021-10-18 | Kumar Ramesh Director | Option exercise | +7,500 | $0.51 | $4K | 7,500 |
| 2021-10-18 | Kumar Ramesh Director | Sale | −7,500 | $8.13 | $61K | 0 |
| 2021-10-18 | Kumar Ramesh Director | Option exercise · Option (Right to Buy) | −7,500 | 31,500 | ||
| 2021-07-19 | Kumar Ramesh Director | Option exercise | +7,500 | $0.51 | $4K | 7,500 |
| 2021-07-19 | Kumar Ramesh Director | Sale | −7,500 | $6.40 | $48K | 0 |
Page 1 of 2 · 26 trades